These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1339766)
21. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin]. Prata MM; de Sousa FT; Barbas JV; da Costa AM; Vinhas J; Moreira P; Abrantes C; Lopes MC Acta Med Port; 1990; 3(3):149-53. PubMed ID: 2220424 [TBL] [Abstract][Full Text] [Related]
22. Improvement of anemia associated with chronic renal failure by recombinant human erythropoietin treatment in ICR-derived glomerulonephritis (ICGN) mice. Yamaguchi-Yamada M; Manabe N; Goto Y; Anan S; Miyamoto K; Miyamoto Y; Nagao M; Yamamoto Y; Ogura A J Vet Med Sci; 2004 Jul; 66(7):883-6. PubMed ID: 15297765 [TBL] [Abstract][Full Text] [Related]
23. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507 [TBL] [Abstract][Full Text] [Related]
24. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747 [TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507 [TBL] [Abstract][Full Text] [Related]
26. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency]. Guízar JM; Gutiérrez MJ; Sánchez G; Kornhauser C Rev Invest Clin; 1996; 48(3):173-7. PubMed ID: 8966377 [TBL] [Abstract][Full Text] [Related]
27. Recombinant human erythropoietin treatment of anemia in renal transplant patients. Lezaic V; Djukanovic L; Pavlovic-Kentera V Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Wingard RL; Parker RA; Ismail N; Hakim RM Am J Kidney Dis; 1995 Mar; 25(3):433-9. PubMed ID: 7872321 [TBL] [Abstract][Full Text] [Related]
29. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency]. Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772 [No Abstract] [Full Text] [Related]
30. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure]. Schaefer RM; Heidland A Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190 [No Abstract] [Full Text] [Related]
31. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218 [TBL] [Abstract][Full Text] [Related]
32. [Effects of recombinant human erythropoietin (SNB-5001) on renal anemic rats induced by drugs]. Masunaga H; Takahira R; Sawai T Nihon Yakurigaku Zasshi; 1991 Aug; 98(2):151-60. PubMed ID: 1916543 [TBL] [Abstract][Full Text] [Related]
33. The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency. Lim VS; Kirchner PT; Fangman J; Richmond J; DeGowin RL Am J Kidney Dis; 1989 Dec; 14(6):496-506. PubMed ID: 2596476 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group. Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941 [TBL] [Abstract][Full Text] [Related]
35. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL. Ayus JC; Go AS; Valderrabano F; Verde E; de Vinuesa SG; Achinger SG; Lorenzo V; Arieff AI; Luño J; Kidney Int; 2005 Aug; 68(2):788-95. PubMed ID: 16014057 [TBL] [Abstract][Full Text] [Related]
36. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial. Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974 [TBL] [Abstract][Full Text] [Related]
37. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159 [TBL] [Abstract][Full Text] [Related]
38. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report. Salim KA; Salim S; Mathew T J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463 [TBL] [Abstract][Full Text] [Related]
39. Iron management during treatment with recombinant human erythropoietin in chronic renal failure. Watson A J Clin Pharmacol; 1993 Dec; 33(12):1134-8. PubMed ID: 8126248 [TBL] [Abstract][Full Text] [Related]
40. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis. Sinai-Trieman L; Salusky IB; Fine RN J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]